SIGA Technologies, Inc. (SIGA) |
|
7.19 0.07 (0.98%)
|
02-07 16:00 |
|
Open: |
7.14 |
Pre. Close: |
7.12 |
|
High:
|
7.21 |
Low:
|
6.955 |
|
Volume:
|
682,821 |
Market Cap:
|
525(M) |
|
|
|
Technical analysis |
as of: 2023-02-07 4:31:44 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 9.21 One year: 9.91 |
| Support: |
Support1: 6.9 Support2: 5.74 |
| Resistance: |
Resistance1: 7.88 Resistance2: 8.48 |
| Pivot: |
7.44  |
| Moving Average: |
MA(5): 7.35 MA(20): 7.54
MA(100): 8.68 MA(250): 10.33  |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 14.1 %D(3): 20.2 |
| RSI: |
RSI(14): 42 |
| 52-week: |
High: 26.98 Low: 5.84 |
| Average Vol(K): |
3-Month: 821 (K) 10-Days: 591 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SIGA ] has closed above bottom band by 8.6%. Bollinger Bands are 67.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 86 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.21 - 7.25 |
7.25 - 7.29 |
|
Low:
|
6.87 - 6.91 |
6.91 - 6.95 |
|
Close:
|
7.13 - 7.19 |
7.19 - 7.25 |
|
Company Description |
|
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York. |
Headline News |
Wed, 08 Feb 2023
SIGA’s PlayNow Records Impressive Revenues, Sparking Gambling Harm Concerns - GamblingNews.com
Tue, 07 Feb 2023
FA’s chair Debbie Hewitt to headline at SIGA’s New York Summit on ... - Inside World Football
Tue, 07 Feb 2023
Monkeypox Treatment Market Strategic Assessment & SWOT ... - Digital Journal
Fri, 03 Feb 2023
In What Direction Will SIGA Technologies Inc.'s (NASDAQ:SIGA ... - The Dwinnex
Mon, 30 Jan 2023
Should You Accumulate SIGA Technologies, Inc. (SIGA) Stock Monday? - InvestorsObserver
Sat, 28 Jan 2023
Allspring Global Investments Holdings LLC sold shares of SIGA ... - Best Stocks
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Outperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers—Specialty & Generic |
| Shares Out. |
74 (M) |
| Shares Float |
39 (M) |
|
% Held by Insiders
|
44 (%) |
|
% Held by Institutions
|
43.8 (%) |
|
Shares Short
|
4,860 (K) |
|
Shares Short P.Month
|
5,470 (K) |
Stock Financials |
|
EPS
|
0.7 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.67 |
|
Profit Margin (%)
|
48.6 |
|
Operating Margin (%)
|
62.8 |
|
Return on Assets (ttm)
|
39.4 |
|
Return on Equity (ttm)
|
55.9 |
|
Qtrly Rev. Growth
|
92.5 |
|
Gross Profit (p.s.)
|
1.43 |
|
Sales Per Share
|
1.98 |
|
EBITDA (p.s.)
|
1.25 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
72 (M) |
|
Levered Free Cash Flow
|
58 (M) |
Stock Valuations |
|
PE Ratio
|
10.12 |
|
PEG Ratio
|
13.6 |
|
Price to Book value
|
4.27 |
|
Price to Sales
|
3.61 |
|
Price to Cash Flow
|
7.37 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
